### BEGIN COMPANY REPORT
Company: Booking Holdings  
Sector: Consumer Discretionary  
Industry: Hotels, Resorts & Cruise Lines

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 4/5
- Dimension 2 (Data Infrastructure and Analytics): 3/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 4/5
- Dimension 4 (Human Capital and AI Skills): 3/5
- Dimension 5 (AI Governance and Responsible Implementation): 3/5

**Overall AI-Readiness Score:** 3.65/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "Further integrating generative artificial intelligence ('Gen AI') technology into our offerings to add value for consumers and partners; using Gen AI to drive efficiencies in our operations."
- **Dimension 2 Evidence:** No specific mention of advanced data infrastructure; general references to consumer data and operational efficiencies.
- **Dimension 3 Evidence:** "Increasing adoption of our payments platform and capabilities," indicating a focus on digital infrastructure.
- **Dimension 4 Evidence:** "Our ability to attract and retain qualified personnel," but no specific mention of AI-specific talent strategies.
- **Dimension 5 Evidence:** "Our implementation of AI systems could result in legal liability, regulatory action," indicating awareness of AI risks but lacking detailed governance frameworks.

**Strategic AI Positioning:** AI is a strategic differentiator for Booking Holdings, enhancing consumer and partner experiences through Gen AI integration and operational efficiencies.

**Contextual Considerations:** As a leading player in the travel technology sector, Booking Holdings' focus on AI reflects its need to maintain a competitive edge in a rapidly evolving digital landscape.

**Confidence Level:** Medium - The report provides a good overview of AI integration but lacks detailed evidence on data infrastructure and AI governance.

### END COMPANY REPORT

### BEGIN COMPANY REPORT
Company: Boston Scientific  
Sector: Health Care  
Industry: Health Care Equipment

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 3/5
- Dimension 2 (Data Infrastructure and Analytics): 3/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 3/5
- Dimension 4 (Human Capital and AI Skills): 2/5
- Dimension 5 (AI Governance and Responsible Implementation): 2/5

**Overall AI-Readiness Score:** 2.85/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "Digital technologies, including artificial intelligence (AI) and machine learning capabilities, have and may continue to increase in their applicability and importance to various aspects of our business."
- **Dimension 2 Evidence:** No specific mention of advanced data infrastructure or analytics capabilities.
- **Dimension 3 Evidence:** General mention of digital technologies, but no specific details on technology infrastructure.
- **Dimension 4 Evidence:** No specific mention of AI talent acquisition or training programs.
- **Dimension 5 Evidence:** "AI presents significant opportunities for innovation and efficiency, it could introduce new risks," indicating awareness but lacking detailed governance frameworks.

**Strategic AI Positioning:** AI is seen as a business enabler, with potential to enhance R&D and operational efficiency, but not yet a core strategic driver.

**Contextual Considerations:** As a healthcare equipment provider, Boston Scientific's AI initiatives are likely influenced by the need for innovation in medical technologies and operational efficiencies.

**Confidence Level:** Medium - The report provides a general overview of AI's role but lacks detailed evidence on specific initiatives or governance.

### END COMPANY REPORT

### BEGIN COMPANY REPORT
Company: Bristol Myers Squibb  
Sector: Health Care  
Industry: Pharmaceuticals

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 4/5
- Dimension 2 (Data Infrastructure and Analytics): 4/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 3/5
- Dimension 4 (Human Capital and AI Skills): 3/5
- Dimension 5 (AI Governance and Responsible Implementation): 3/5

**Overall AI-Readiness Score:** 3.65/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "Increasing use of artificial intelligence, we are increasing our R&D productivity, enabling us to identify more high-quality candidates."
- **Dimension 2 Evidence:** "We are dependent on information technology systems, including artificial intelligence programs," indicating a mature data infrastructure.
- **Dimension 3 Evidence:** No specific mention of advanced technology infrastructure.
- **Dimension 4 Evidence:** No specific mention of AI talent acquisition or training programs.
- **Dimension 5 Evidence:** "The regulatory landscape related to AI remains uncertain," indicating awareness but lacking detailed governance frameworks.

**Strategic AI Positioning:** AI is a strategic differentiator, enhancing R&D productivity and enabling the identification of high-quality candidates in drug development.

**Contextual Considerations:** As a pharmaceutical company, Bristol Myers Squibb's focus on AI is critical for maintaining competitiveness in drug discovery and development.

**Confidence Level:** Medium - The report provides a strong overview of AI's strategic role but lacks detailed evidence on technology infrastructure and governance.

### END COMPANY REPORT

### BEGIN COMPANY REPORT
Company: Broadcom  
Sector: Information Technology  
Industry: Semiconductors

**Dimension Scores:**
- Dimension 1 (AI Strategy and Vision): 5/5
- Dimension 2 (Data Infrastructure and Analytics): 4/5
- Dimension 3 (Technology Infrastructure and Digital Capabilities): 5/5
- Dimension 4 (Human Capital and AI Skills): 4/5
- Dimension 5 (AI Governance and Responsible Implementation): 3/5

**Overall AI-Readiness Score:** 4.50/5.00  
(Calculated as: D1×0.35 + D2×0.25 + D3×0.20 + D4×0.15 + D5×0.05)

**Key Evidence Summary:**
- **Dimension 1 Evidence:** "Our products offer an enhanced, open, standards-based Ethernet network interface card ('NIC') and switching solution to resolve connectivity bottlenecks in data centers, particularly in AI data centers."
- **Dimension 2 Evidence:** "Advanced services for Private AI provide customers with the benefits of AI without having to compromise control of data, privacy, and compliance."
- **Dimension 3 Evidence:** "VCF includes native Kubernetes to support both virtual machines and containerized workloads on a single platform, enables advanced AI and machine learning workloads at enterprise scale."
- **Dimension 4 Evidence:** "Our engineering and technical personnel, such as our AI-related product engineers and cybersecurity experts, are a significant asset."
- **Dimension 5 Evidence:** No specific mention of detailed AI governance frameworks.

**Strategic AI Positioning:** AI is a core business driver, integral to Broadcom's product offerings and competitive advantage in the semiconductor industry.

**Contextual Considerations:** As a leading semiconductor company, Broadcom's advanced AI capabilities are crucial for maintaining its leadership in technology infrastructure and innovation.

**Confidence Level:** High - The report provides detailed evidence of AI's central role in Broadcom's strategy and operations.

### END COMPANY REPORT